194 related articles for article (PubMed ID: 32245796)
1. Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Is Associated with Indigenous American Ancestry in Latin American Women.
Marker KM; Zavala VA; Vidaurre T; Lott PC; Vásquez JN; Casavilca-Zambrano S; Calderón M; Abugattas JE; Gómez HL; Fuentes HA; Picoaga RL; Cotrina JM; Neciosup SP; Castañeda CA; Morante Z; Valencia F; Torres J; Echeverry M; Bohórquez ME; Polanco-Echeverry G; Estrada-Florez AP; Serrano-Gómez SJ; Carmona-Valencia JA; Alvarado-Cabrero I; Sanabria-Salas MC; Velez A; Donado J; Song S; Cherry D; Tamayo LI; Huntsman S; Hu D; Ruiz-Cordero R; Balassanian R; Ziv E; Zabaleta J; Carvajal-Carmona L; Fejerman L;
Cancer Res; 2020 May; 80(9):1893-1901. PubMed ID: 32245796
[TBL] [Abstract][Full Text] [Related]
2. Association between Ancestry-Specific 6q25 Variants and Breast Cancer Subtypes in Peruvian Women.
Zavala VA; Casavilca-Zambrano S; Navarro-Vásquez J; Castañeda CA; Valencia G; Morante Z; Calderón M; Abugattas JE; Gómez H; Fuentes HA; Liendo-Picoaga R; Cotrina JM; Monge C; Neciosup SP; Huntsman S; Hu D; Sánchez SE; Williams MA; Núñez-Marrero A; Godoy L; Hechmer A; Olshen AB; Dutil J; Ziv E; Zabaleta J; Gelaye B; Vásquez J; Gálvez-Nino M; Enriquez-Vera D; Vidaurre T; Fejerman L
Cancer Epidemiol Biomarkers Prev; 2022 Aug; 31(8):1602-1609. PubMed ID: 35654312
[TBL] [Abstract][Full Text] [Related]
3. Breast cancer subtype and clinical characteristics in women from Peru.
Zavala VA; Casavilca-Zambrano S; Navarro-Vásquez J; Tamayo LI; Castañeda CA; Valencia G; Morante Z; Calderón M; Abugattas JE; Gómez HL; Fuentes HA; Liendo-Picoaga R; Cotrina JM; Neciosup SP; Roque K; Vásquez J; Mas L; Gálvez-Nino M; Fejerman L; Vidaurre T
Front Oncol; 2023; 13():938042. PubMed ID: 36925912
[TBL] [Abstract][Full Text] [Related]
4. Racial comparison of receptor-defined breast cancer in Southern African women: subtype prevalence and age-incidence analysis of nationwide cancer registry data.
Dickens C; Duarte R; Zietsman A; Cubasch H; Kellett P; Schüz J; Kielkowski D; McCormack V
Cancer Epidemiol Biomarkers Prev; 2014 Nov; 23(11):2311-21. PubMed ID: 25143359
[TBL] [Abstract][Full Text] [Related]
5. Age-specific incidence of breast cancer subtypes: understanding the black-white crossover.
Clarke CA; Keegan TH; Yang J; Press DJ; Kurian AW; Patel AH; Lacey JV
J Natl Cancer Inst; 2012 Jul; 104(14):1094-101. PubMed ID: 22773826
[TBL] [Abstract][Full Text] [Related]
6. Translational Epidemiology: An Integrative Approach to Determine the Interplay Between Genetic Ancestry and Neighborhood Socioeconomic Status on Triple Negative Breast Cancer.
Goel N; Yadegarynia S; Kwon D; Kesmodel SB; Harbour JW; Kobetz E; Merchant N; Rodriguez DA
Ann Surg; 2022 Sep; 276(3):430-440. PubMed ID: 35758508
[TBL] [Abstract][Full Text] [Related]
7. Racial disparities in breast cancer diagnosis and treatment by hormone receptor and HER2 status.
Chen L; Li CI
Cancer Epidemiol Biomarkers Prev; 2015 Nov; 24(11):1666-72. PubMed ID: 26464428
[TBL] [Abstract][Full Text] [Related]
8. Annual Report to the Nation on the Status of Cancer, 1975-2011, Featuring Incidence of Breast Cancer Subtypes by Race/Ethnicity, Poverty, and State.
Kohler BA; Sherman RL; Howlader N; Jemal A; Ryerson AB; Henry KA; Boscoe FP; Cronin KA; Lake A; Noone AM; Henley SJ; Eheman CR; Anderson RN; Penberthy L
J Natl Cancer Inst; 2015 Jun; 107(6):djv048. PubMed ID: 25825511
[TBL] [Abstract][Full Text] [Related]
9. Genetic ancestry modifies the association between genetic risk variants and breast cancer risk among Hispanic and non-Hispanic white women.
Fejerman L; Stern MC; Ziv E; John EM; Torres-Mejia G; Hines LM; Wolff R; Wang W; Baumgartner KB; Giuliano AR; Slattery ML
Carcinogenesis; 2013 Aug; 34(8):1787-93. PubMed ID: 23563089
[TBL] [Abstract][Full Text] [Related]
10. Racial Differences in the Use and Outcome of Neoadjuvant Chemotherapy for Breast Cancer: Results From the National Cancer Data Base.
Killelea BK; Yang VQ; Wang SY; Hayse B; Mougalian S; Horowitz NR; Chagpar AB; Pusztai L; Lannin DR
J Clin Oncol; 2015 Dec; 33(36):4267-76. PubMed ID: 26598753
[TBL] [Abstract][Full Text] [Related]
11. Genetic ancestry and risk factors for breast cancer among Latinas in the San Francisco Bay Area.
Ziv E; John EM; Choudhry S; Kho J; Lorizio W; Perez-Stable EJ; Burchard EG
Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1878-85. PubMed ID: 17035394
[TBL] [Abstract][Full Text] [Related]
12. Advanced stages and poorly differentiated grade are associated with an increased risk of HER2/neu positive breast carcinoma only in White women: findings from a prospective cohort study of African-American and White-American women.
Stark A; Kapke A; Schultz D; Brown R; Linden M; Raju U
Breast Cancer Res Treat; 2008 Feb; 107(3):405-14. PubMed ID: 17431759
[TBL] [Abstract][Full Text] [Related]
13. US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status.
Howlader N; Altekruse SF; Li CI; Chen VW; Clarke CA; Ries LA; Cronin KA
J Natl Cancer Inst; 2014 Apr; 106(5):. PubMed ID: 24777111
[TBL] [Abstract][Full Text] [Related]
14. Mortality risk of black women and white women with invasive breast cancer by hormone receptors, HER2, and p53 status.
Ma H; Lu Y; Malone KE; Marchbanks PA; Deapen DM; Spirtas R; Burkman RT; Strom BL; McDonald JA; Folger SG; Simon MS; Sullivan-Halley J; Press MF; Bernstein L
BMC Cancer; 2013 May; 13():225. PubMed ID: 23642215
[TBL] [Abstract][Full Text] [Related]
15. Race and triple negative threats to breast cancer survival: a population-based study in Atlanta, GA.
Lund MJ; Trivers KF; Porter PL; Coates RJ; Leyland-Jones B; Brawley OW; Flagg EW; O'Regan RM; Gabram SG; Eley JW
Breast Cancer Res Treat; 2009 Jan; 113(2):357-70. PubMed ID: 18324472
[TBL] [Abstract][Full Text] [Related]
16. Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups.
Kurian AW; Fish K; Shema SJ; Clarke CA
Breast Cancer Res; 2010; 12(6):R99. PubMed ID: 21092082
[TBL] [Abstract][Full Text] [Related]
17. Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study.
Troester MA; Sun X; Allott EH; Geradts J; Cohen SM; Tse CK; Kirk EL; Thorne LB; Mathews M; Li Y; Hu Z; Robinson WR; Hoadley KA; Olopade OI; Reeder-Hayes KE; Earp HS; Olshan AF; Carey LA; Perou CM
J Natl Cancer Inst; 2018 Feb; 110(2):176-82. PubMed ID: 28859290
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer subtypes as defined by the estrogen receptor (ER), progesterone receptor (PR), and the human epidermal growth factor receptor 2 (HER2) among women with invasive breast cancer in California, 1999-2004.
Parise CA; Bauer KR; Brown MM; Caggiano V
Breast J; 2009; 15(6):593-602. PubMed ID: 19764994
[TBL] [Abstract][Full Text] [Related]
19. Genetic ancestry and risk of mortality among U.S. Latinas with breast cancer.
Fejerman L; Hu D; Huntsman S; John EM; Stern MC; Haiman CA; Pérez-Stable EJ; Ziv E
Cancer Res; 2013 Dec; 73(24):7243-53. PubMed ID: 24177181
[TBL] [Abstract][Full Text] [Related]
20. Prognostic features of breast cancer differ between women in the Democratic Republic of Congo and Belgium.
Luyeye Mvila G; Batalansi D; Praet M; Marchal G; Laenen A; Christiaens MR; Brouckaert O; Ali-Risasi C; Neven P; Van Ongeval C
Breast; 2015 Oct; 24(5):642-8. PubMed ID: 26279132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
